Business Wire

Emulate, Inc. Appoints Jim Corbett as Chief Executive Officer and Martin Madaus, PhD, as Executive Chairman

BOSTON--(BUSINESS WIRE)--Emulate, Inc., today announced that Jim Corbett has been appointed as Chief Executive Officer and Martin Madaus, Ph.D., has been appointed Executive Chairman of the company’s ...
Business Wire

Emulate, Inc. Announces Strategic Partnership with Leading Pharmaceutical Company to Apply the ‘Human Emulation System’ as a Platform for Drug Discovery

BOSTON--(BUSINESS WIRE)--Emulate, Inc. announced today that it has formed a strategic partnership with F Hoffman La-Roche AG (Roche) that will use Emulate’s Human Emulation System across R&D programs ...
The Scientist

Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications

Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance ...
News Medical

AstraZeneca collaborates with Emulate to integrate Organs-on-Chips technology into drug development labs

Emulate, Inc. has formed a collaborative partnership with AstraZeneca’s Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-Chips technology within the laboratories ...
PE Hub

Emulate secures $12 mln Series A

Emulate, Inc. today announced the company’s launch with a $12 million Series A financing to commercialize a first-in-kind, automated ‘Organs-on-Chips’ platform that mimics human physiology and ...
EurekAlert!

Cedars-Sinai and Emulate, Inc. advance precision medicine with organs-on-chips, stem cells

LOS ANGELES and BOSTON (Feb. 20, 2018) - Scientists at Cedars-Sinai and Emulate, Inc. are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based ...
Yahoo

Emulate Inc. closes $82M Series E to fund expansion of 'organ-on-a-chip' products

Emulate Inc., a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. This latest round is intended to formulate a massive investment in ...
News Medical

Emulate partners with AstraZeneca to accelerate development of Organs-on-Chips technology

Emulate, Inc. has formed a collaborative partnership with AstraZeneca's Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-Chips technology within the laboratories ...
SpaceNews

Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station

Emulate, Inc., a leading provider of next-generation in vitro models, today announced that the Brain-Chip is being sent to the International Space Station U.S. National Laboratory (ISS National Lab) ...
Wall Street Journal

Emulate Picks Up $28M Series B for ‘Organs on Chips’

A number of companies looking for new approaches to testing their drugs and other products are turning to “organs-on-chips” technology from Emulate Inc., which has secured $28 million in Series B ...
FierceBiotech

Emulate, Inc. Awarded Michael J. Fox Foundation Grant to use Organs-on-Chips to Investigate Drug Candidates for Treatment of Parkinson's Disease

Emulate, Inc. Awarded Michael J. Fox Foundation Grant to use Organs-on-Chips to Investigate Drug Candidates for Treatment of Parkinson's Disease The studies will evaluate potential safety challenges ...